Cargando…
Validation of the online PREDICT tool in a cohort of early breast cancer in Brazil
PREDICT is a tool designed to estimate the benefits of adjuvant therapy and the overall survival of women with early breast cancer. The model uses clinical, histological, and immunohistochemical variables. This study aimed to evaluate the model's performance in a Brazilian population. We assess...
Autores principales: | Magário, M.B., dos Santos, R.R., Teixeira, L.A., Tiezzi, D.G., Pimentel, F.F., Carrara, H.H.A., de Andrade, J.M., dos Reis, F.J. Candido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635813/ https://www.ncbi.nlm.nih.gov/pubmed/36350970 http://dx.doi.org/10.1590/1414-431X2022e12109 |
Ejemplares similares
-
1747P Chemotherapy prescriptions and emergency medical care utilization by patients in neo/adjuvant breast cancer treatment during COVID-19 pandemic: Patterns in a Brazilian University Hospital
por: Pimentel, F.F., et al.
Publicado: (2020) -
Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients
por: Orlandini, L.F., et al.
Publicado: (2021) -
Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors
por: Buzatto, I.P.C., et al.
Publicado: (2017) -
Current Breast Cancer Screening Scenario in Brazil
por: Tiezzi, Daniel Guimarães, et al.
Publicado: (2019) -
Oral health after breast cancer treatment in postmenopausal women
por: Amódio, Juliana, et al.
Publicado: (2014)